We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Andrx Did Not Investigate Product Deviations, Form 483 Says
Andrx Did Not Investigate Product Deviations, Form 483 Says
May 16, 2006
Andrx did not properly investigate product discrepancies and out-of-specification results, according to observations listed on the Form 483 the FDA issued to the company after the agency’s reinspection of the drugmaker’s plant in March.